How to dramatically reduce dehydration-related readmission in patients undergoing restorative surgery with diverting ileostomy for ulcerative colitis.


Journal

Techniques in coloproctology
ISSN: 1128-045X
Titre abrégé: Tech Coloproctol
Pays: Italy
ID NLM: 9613614

Informations de publication

Date de publication:
22 Sep 2024
Historique:
received: 03 01 2024
accepted: 09 08 2024
medline: 22 9 2024
pubmed: 22 9 2024
entrez: 22 9 2024
Statut: epublish

Résumé

Patients affected by ulcerative colitis (UC) often require surgery, involving two or three-stage procedures, including ileostomy creation. While ileostomy has some advantages, it can lead to complications, such as dehydration. The aim of this study was to evaluate the impact of a new individualized stoma-therapeutic-care-pathway (STCP) on dehydration-related readmissions. Secondary endpoints were stoma-related complications. The study compares two series of consecutive patients with UC undergoing diverting ileostomy during restorative ileo-pouch-anal-anastomosis. The STCP group consists of patients enrolled from January 2020 to December 2021 who followed the pathway. The older group was selected from 2015 to 2017 (control group). Clinical data were collected, including patient characteristics, hospital stay, complications, and readmissions. The study was approved by the local institutional review board. Overall, 30-day dehydration-related readmission occurred in one (1.4%) versus nine (15.3%) patients in the STCP group versus control group, respectively (p = 0.005). In-hospital peristomal skin complications were significantly lower in STCP group (6 patients, 8.5%) versus control (35, 59.3%), as well as ostomy complications that occurred in 5 (7%) patients in the STCP group versus 8 (13.5%) in the control group (both p < 0.001). Ostomy complications reduced significantly in the STCP group after discharge (two patients, 2.8% versus eight, 13.5%), p = 0.001, and after 30-days (three patients, 4.2% versus five, 8.5%). This study underscores the effectiveness of STCP in reducing dehydration-related readmissions and stoma-related complications in patients with UC undergoing stoma creation. It emphasizes the significance of patient education, close follow-up, and multidisciplinary care. Further research and standardized stoma education are essential.

Sections du résumé

BACKGROUND BACKGROUND
Patients affected by ulcerative colitis (UC) often require surgery, involving two or three-stage procedures, including ileostomy creation. While ileostomy has some advantages, it can lead to complications, such as dehydration. The aim of this study was to evaluate the impact of a new individualized stoma-therapeutic-care-pathway (STCP) on dehydration-related readmissions. Secondary endpoints were stoma-related complications.
METHODS METHODS
The study compares two series of consecutive patients with UC undergoing diverting ileostomy during restorative ileo-pouch-anal-anastomosis. The STCP group consists of patients enrolled from January 2020 to December 2021 who followed the pathway. The older group was selected from 2015 to 2017 (control group). Clinical data were collected, including patient characteristics, hospital stay, complications, and readmissions. The study was approved by the local institutional review board.
RESULTS RESULTS
Overall, 30-day dehydration-related readmission occurred in one (1.4%) versus nine (15.3%) patients in the STCP group versus control group, respectively (p = 0.005). In-hospital peristomal skin complications were significantly lower in STCP group (6 patients, 8.5%) versus control (35, 59.3%), as well as ostomy complications that occurred in 5 (7%) patients in the STCP group versus 8 (13.5%) in the control group (both p < 0.001). Ostomy complications reduced significantly in the STCP group after discharge (two patients, 2.8% versus eight, 13.5%), p = 0.001, and after 30-days (three patients, 4.2% versus five, 8.5%).
CONCLUSIONS CONCLUSIONS
This study underscores the effectiveness of STCP in reducing dehydration-related readmissions and stoma-related complications in patients with UC undergoing stoma creation. It emphasizes the significance of patient education, close follow-up, and multidisciplinary care. Further research and standardized stoma education are essential.

Identifiants

pubmed: 39306805
doi: 10.1007/s10151-024-03001-6
pii: 10.1007/s10151-024-03001-6
doi:

Types de publication

Journal Article Comparative Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

129

Informations de copyright

© 2024. Springer Nature Switzerland AG.

Références

Park J, Gessler B, Block M, Angenete E (2018) Complications and morbidity associated with loop ileostomies in patients with ulcerative colitis. Scand J Surg 107:38–42. https://doi.org/10.1177/1457496917705995
doi: 10.1177/1457496917705995 pubmed: 28485190
Fish DR, Mancuso CA, Garcia-Aguilar JE et al (2017) Readmission after ileostomy creation retrospective review of a common and significant event. Annals of Surgery. Lippincott Williams and Wilkins, pp 379–387
Van Butsele J, Bislenghi G, D’Hoore A, Wolthuis AM (2021) Readmission after rectal resection in the ERAS-era: is a loop ileostomy the Achilles heel? BMC Surg. https://doi.org/10.1186/s12893-021-01242-y
doi: 10.1186/s12893-021-01242-y pubmed: 34044794 pmcid: 8161575
Liu C, Bhat S, Sharma P et al (2021) Risk factors for readmission with dehydration after ileostomy formation: a systematic review and meta-analysis. Colorectal Dis 23:1071–1082
doi: 10.1111/codi.15566 pubmed: 33539646
Justiniano CF, Temple LK, Swanger AA et al (2018) Readmissions with dehydration after ileostomy creation: rethinking risk factors. Dis Colon Rectum 61:1297–1305. https://doi.org/10.1097/DCR.0000000000001137
doi: 10.1097/DCR.0000000000001137 pubmed: 30239391 pmcid: 6172143
Paquette IM, Solan P, Rafferty JF et al (2013) Readmission for dehydration or renal failure after ileostomy creation. Dis Colon Rectum 56:974–979. https://doi.org/10.1097/DCR.0b013e31828d02ba
doi: 10.1097/DCR.0b013e31828d02ba pubmed: 23838866
Karjalainen EK, Renkonen-Sinisalo L, Mustonen HK, Lepistö AH (2019) Morbidity related to diverting ileostomy after restorative proctocolectomy in patients with ulcerative colitis. Colorectal Dis 21:671–678. https://doi.org/10.1111/codi.14573
doi: 10.1111/codi.14573 pubmed: 30698869
Grahn SW, Lowry AC, Osborne MC et al (2019) System-wide improvement for transitions after ileostomy surgery: can intensive monitoring of protocol compliance decrease readmissions? A randomized trial. Dis Colon Rectum 62:363–370. https://doi.org/10.1097/DCR.0000000000001286
doi: 10.1097/DCR.0000000000001286 pubmed: 30489324
Mineccia M, Valenti A, Gonella F et al (2022) A close adherence to a stoma-therapeutic pathway improves immediate stoma-related outcomes and reduces the length of hospital stay. Int J Colorectal Dis 37:1719–1725. https://doi.org/10.1007/s00384-022-04200-z
doi: 10.1007/s00384-022-04200-z pubmed: 35688952
Vogel I, Shinkwin M, van der Storm SL et al (2022) Overall readmissions and readmissions related to dehydration after creation of an ileostomy: a systematic review and meta-analysis. Tech Coloproctol 26:333–349
doi: 10.1007/s10151-022-02580-6 pubmed: 35192122 pmcid: 9018644
Lederhuber H, Massey LH, Kantola VE et al (2023) Clinical management of high-output stoma: a systematic literature review and meta-analysis. Tech Coloproctol. https://doi.org/10.1007/s10151-023-02830-1
doi: 10.1007/s10151-023-02830-1 pubmed: 37330988
von Elm E, Altman DG, Egger M et al (2014) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Int J Surg 12:1495–1499. https://doi.org/10.1016/j.ijsu.2014.07.013
doi: 10.1016/j.ijsu.2014.07.013
Messaris E, Sehgal R, Deiling S et al (2012) Dehydration is the most common indication for readmission after diverting ileostomy creation. Dis Colon Rectum 55:175–180. https://doi.org/10.1097/DCR.0b013e31823d0ec5
doi: 10.1097/DCR.0b013e31823d0ec5 pubmed: 22228161
Raza A, Iqbal A, Huang E et al (2017) Cost effectiveness of a novel attempt to reduce readmission after ileostomy creation. J Soc Laparoendosc Surg. https://doi.org/10.4293/JSLS.2016.00082
doi: 10.4293/JSLS.2016.00082
Shaffer VO, Owi T, Kumarusamy MA et al (2017) Decreasing Hospital Readmission in Ileostomy Patients: Results of Novel Pilot Program. Journal of the American College of Surgeons. Elsevier Inc., pp 425–430
van Loon YT, Clermonts SHEM, Belt R et al (2020) Implementation of an easy in-hospital educational stoma pathway results in decrease of home nursing care services after discharge. Colorectal Dis 22:1175–1183. https://doi.org/10.1111/codi.15034
doi: 10.1111/codi.15034 pubmed: 32180331
Gonella F, Valenti A, Massucco P et al (2019) A novel patient-centered protocol to reduce hospital readmissions for dehydration after ileostomy. Updates Surg 71:515–521. https://doi.org/10.1007/s13304-019-00643-2
doi: 10.1007/s13304-019-00643-2 pubmed: 30887466
Huang X, Xiao M, Jiang B et al (2022) Prevalence of frailty among patients with inflammatory bowel disease and its association with clinical outcomes: a systematic review and meta-analysis. BMC Gastroenterol. https://doi.org/10.1186/s12876-022-02620-3
doi: 10.1186/s12876-022-02620-3 pubmed: 36581813 pmcid: 9801670
Joseph B, Pandit V, Zangbar B et al (2014) Superiority of frailty over age in predicting outcomes among geriatric trauma patients: a prospective analysis. JAMA Surg 149:766–772. https://doi.org/10.1001/jamasurg.2014.296
doi: 10.1001/jamasurg.2014.296 pubmed: 24920308
Arolfo S, Borgiotto C, Bosio G et al (2018) Preoperative stoma site marking: a simple practice to reduce stoma-related complications. Tech Coloproctol 22:683–687. https://doi.org/10.1007/s10151-018-1857-3
doi: 10.1007/s10151-018-1857-3 pubmed: 30267265
Malik TAM, Lee MJ, Harikrishnan AB (2018) The incidence of stoma related morbidity—a systematic review of randomised controlled trials. Ann R Coll Surg Engl 100:501–508
doi: 10.1308/rcsann.2018.0126 pubmed: 30112948 pmcid: 6214073

Auteurs

M Mineccia (M)

Department of Chirurgia Generale E Oncologica, Ospedale Mauriziano Umberto I, Largo Turati 62, 10100, Turin, Italy. mmineccia@mauriziano.it.

A Valenti (A)

Department of Chirurgia Generale E Oncologica, Ospedale Mauriziano Umberto I, Largo Turati 62, 10100, Turin, Italy.

P Massucco (P)

Department of Chirurgia Generale E Oncologica, Ospedale Mauriziano Umberto I, Largo Turati 62, 10100, Turin, Italy.

S Dagatti (S)

Department of Chirurgia Generale E Oncologica, Ospedale Mauriziano Umberto I, Largo Turati 62, 10100, Turin, Italy.
Division of Chirurgia Generale, ASL AT, Ospedale Cardinal Massaia, Corso Dante Alighieri 202, 14100, Asti, Italy.

S Perotti (S)

Department of Chirurgia Generale E Oncologica, Ospedale Mauriziano Umberto I, Largo Turati 62, 10100, Turin, Italy.

F Fazio (F)

Department of Chirurgia Generale E Oncologica, Ospedale Mauriziano Umberto I, Largo Turati 62, 10100, Turin, Italy.

A Ferrero (A)

Department of Chirurgia Generale E Oncologica, Ospedale Mauriziano Umberto I, Largo Turati 62, 10100, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH